Young man playing the piano, with a yellow light beam swirl
Young man playing the piano, with a yellow light beam swirl

NOW APPROVED: 
Infilbray™ (venglustat)

A neurologic breakthrough in GD3: Infilbray is the first and only treatment for neurologic symptoms of Gaucher disease type 3 (GD3)*

*Approved for use in adults and children who weigh at least 33 pounds (15 kg).

Icon of a magnifying glass, indicating analysis

Neurologic efficacy

Analyzed through cognitive and motor function scores

Icon of a brain

Targets the underlying cause

Reduces the body's ability to create GL-1 and lyso-GL-1, helping decrease toxic buildup in the brain and spinal cord

Icon of text reading 1x DAILY

Convenient, oral dosing

Tablet taken once daily

Ask your doctor if Infilbray is right for you or your loved one.

Icon of two people in conversation, with a speech bubble containing a heart, representing patient support or care conversation

Getting started on Infilbray

CareConnectTM Personalized Support Services is here to help you start and stay on treatment with Infilbray.

Icon of an envelope, indicating updates and information

Stay connected with us

Get updates and information about Infilbray and Gaucher disease 
type 3.

GL-1=glucosylceramide; lyso-GL-1=glucosylsphingosine.


Important Safety Information
Important Safety Information
Indication

Before taking INFILBRAY, tell your healthcare provider (HCP) about all of your medical conditions, including if you:

  • Have kidney problems.
  • Have or have had a history of suicidal thoughts or actions, depression, or any other mental health problem.
  • Are pregnant or plan to become pregnant. INFILBRAY may harm your unborn baby. Females who are able to become pregnant:
    • Your HCP will do a pregnancy test before you start treatment.
    • Use effective birth control during treatment and for 11 days after your last dose.
    • Tell your HCP right away if you become pregnant or think that you may be pregnant during treatment.
  • Are breastfeeding or plan to breastfeed. It is not known if INFILBRAY passes into your breast milk. Talk to your HCP about the best way to feed your baby. If you breastfeed during treatment, your baby may need eye exams with an eye specialist (ophthalmologist).


Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking INFILBRAY with certain other medicines may affect how it works and increase the risk of side effects.

What are the possible side effects of INFILBRAY?

INFILBRAY may cause serious side effects including:

Suicidal thoughts or actions.
INFILBRAY may cause suicidal thoughts or actions, depression, or other mood changes. Before starting treatment, your HCP will check your risk for mental health problems. Pay close attention to and tell your HCP about any behavior changes, especially suicidal thoughts or actions, new or worsening changes in depression, mood, behaviors, thoughts, or feelings.

Tell your HCP right away if you have any of the following symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying, suicide attempts, depression, anxiety, feeling very agitated or restless, panic attacks, trouble sleeping (insomnia), irritability, acting aggressive, being angry or violent, acting on dangerous impulses, an extreme increase in activity and/or talking (mania), or other unusual changes in behavior or mood.

Your HCP may stop treatment with INFILBRAY if you develop mental health problems.

Clouding of the eye’s lens (lens opacification) in children. Cloudiness of the eye lens may happen in children during long-term (chronic) treatment. Children will have their eyes checked by an eye specialist (ophthalmologist) before starting and once a year during treatment. Tell your child’s HCP if your child gets any vision changes during treatment including: clouded, blurred, or dim vision, trouble seeing in sunlight or bright lights, or trouble seeing at night.

The most common side effects of INFILBRAY include: diarrhea, enlarged spleen, nausea, depression, irritation or infection of the stomach and intestine (gastroenteritis), and vomiting.

These are not all of the possible side effects of INFILBRAY.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Indication

What is INFILBRAY (venglustat)?
INFILBRAY is a prescription medicine used for the treatment of neurological (nervous system) symptoms in Type 3 Gaucher disease (GD3) in adults and children weighing at least 33 pounds (15 kg).

It is not known if INFILBRAY is safe and effective in children under 33 pounds.

MAT-US-2610589-v1.0-11/2026. Last updated: November 2026